Basics Lantheus Holdings, Inc. Lantheus Holdings Inc develops diagnostic products for the healthcare sector. Its chief product is imaging agents used by physicians in diagnostic procedures such as cardiac ultrasounds and X-ray imaging. IPO Date: June 25, 2015 Sector: Healthcare Industry: Medical Diagnostics and Research Market Cap: $5.24B Activated in VL: True Average Daily Range Avg Daily Range: $0.75 | 2.32% Avg Daily Range (30 D): $1.52 | 1.69% Avg Daily Range (90 D): $2.08 | 2.26% Institutional Daily Volume Avg Daily Volume: .54M Avg Daily Volume (30 D): 1.08M Avg Daily Volume (90 D): .87M Trade Size Avg Trade Size (Sh.): 67 Avg Trade Size (Sh.) (30 D): 46 Avg Trade Size (Sh.) (90 D): 43 Institutional Trades Total Inst.Trades: 5,112 Avg Inst. Trade: $3.2M Avg Inst. Trade (30 D): $3.89M Avg Inst. Trade (90 D): $4.54M Avg Inst. Trade Volume: .06M Avg Inst. Trades (Per Day): 3 Market Closing Trades Avg Closing Trade: $5.34M Avg Closing Trade (30 D): $10.11M Avg Closing Trade (90 D): $10.53M Avg Closing Volume: 99.81K         News May 14, 2025 @ 6:50 PM Radiopharmaceuticals Market Products and Applicati... Source: N/A Feb 27, 2025 @ 4:02 PM Lantheus' Pylarify Hit $1B in 2024 Sales Source: David Kretzmann Jan 29, 2025 @ 9:30 AM Why Lantheus Holdings Stock Got Thrashed on Tuesda... Source: Eric Volkman Jan 28, 2025 @ 3:32 PM Lantheus To Buy Evergreen Theragnostics For Over $... Source: Vandana Singh Jan 28, 2025 @ 11:00 AM Lantheus to Acquire Evergreen Theragnostics for Up... Source: N/A Financials   TTM Q1 2025 Q4 2024 Basic EPS $3.67 $1.06 $-.17 Diluted EPS $3.5 $1.02 $-.19 Revenue $ 1.54B $ 372.76M $ 391.11M Gross Profit $ 984.15M $ 237.7M $ 248.55M Net Income / Loss $ 254.32M $ 72.95M $ -11.79M Operating Income / Loss $ 452.41M $ 102.07M $ 113.87M Cost of Revenue $ 552.55M $ 135.06M $ 142.57M Net Cash Flow $ 220.3M $ 25.73M $ 46.44M PE Ratio 21.99